4.7 Article

Complexity in Influenza Virus Targeted Drug Design: Interaction with Human Sialidases

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 53, Issue 7, Pages 2998-3002

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jm100078r

Keywords

-

Funding

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan [16570104]
  2. National Health and Medical Research Council
  3. Australian Research Council
  4. Federation Fellowship
  5. Italian Ministry of Instruction, University and Research
  6. Fondazione Cariplo
  7. Grants-in-Aid for Scientific Research [16570104] Funding Source: KAKEN

Ask authors/readers for more resources

With the global spread of the pandemic H1N1 and the ongoing pandemic potential of the H5N1 subtype, the influenza virus represents one of the most alarming viruses spreading worldwide. The influenza virus sialidase is an effective drug target, and a number of inhibitors are clinically effective against the virus (zanamivir, oseltamivir, peramivir). Here we report structural and biochemical studies of the human cytosolic sialidase Neu2 with influenza virus sialidase-targeting drugs and related compounds.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available